Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Featured

      Daiichi Sankyo Launches NaruveinⓇ Injection for Cancer Pain Treatment in Japan

      Drug Development
      Daiichi Sankyo Company, Limited announced that it has launched in Japan an injection for cancer pain treatment: NaruveinⓇ Injection 2 mg • 20 mg. Hydromorphone...

      Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical...

      Clinical Trials
      Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and tolerability of both quarterly...

      Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

      Europe
      Chemspec Europe has long become the annual get-together of the internationalfine and speciality chemicals industry. For its 33rd edition, the show introduces a new Partnering...

      Lilly, Livongo team up for real-world diabetes research, aiming for better results in an outcomes-oriented market

      Press Statements
      There's a new tech partnership in diabetes, this time between Eli Lilly and Livongo. And it's looking to tap real-world data to deliver better...

      Chinese researchers report first lung stem cell transplantation clinical trial

      Clinical Trials
      A research team from Tongji University in China have made a breakthrough in human lung regeneration technology. For the first time, researchers have regenerated...

      Using injectable self-assembled nanomaterials for sustained delivery of drugs Drug

      Drug Development
      Because they can be programmed to travel the body and selectively target cancer and other sites of disease, nanometer-scale vehicles called nanocarriers can deliver...

      Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease

      Clinical Trials
      Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and Nonalcoholic Steatohepatitis (NASH), announced...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.